Leshan Liu

机构：Shanghai Jiao Tong University

发表论文 15 篇 · 总被引 1535 次 · h-index 5

代表论文

• Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial (2020 · BMJ · 被引 1057)
• Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (2024 · New England Journal of Medicine · 被引 203)
• Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial (2020 · medRxiv · 被引 198)
• Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern (2022 · Nature Communications · 被引 41)
• Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis (2019 · BMC Cancer · 被引 19)
• Neutralizing activity of BBIBP-CorV vaccine-elicited sera against multiple SARS-CoV-2 variants of concern (2021 · Research Square · 被引 3)